Advanced search
Publication Cover
Emerging Microbes & Infections Volume 13, 2024 - Issue 1
Submit an article Journal homepage
265
Views
0
CrossRef citations to date
0
Altmetric
Research Letter

Identification of the VP37 pocket of monkeypox virus as a promising target for pan-orthopoxvirus inhibitors through virtual screening and antiviral assays

Shuting Huoa NHC Key Laboratory of Biosafety, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, People’s Republic of ChinaView further author information
,
Leyun Wub State Key Laboratory of Drug Research; Drug Discovery and Design Center, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, People’s Republic of ChinaView further author information
,
Baoying Huanga NHC Key Laboratory of Biosafety, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, People’s Republic of ChinaView further author information
,
Nan Liuc Center for Drug Safety Evaluation and Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, People’s Republic of ChinaView further author information
,
Jiewei Sund School of Pharmacy, Xinxiang Medical University, Xinxiang, People’s Republic of ChinaView further author information
,
Fei Yea NHC Key Laboratory of Biosafety, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, People’s Republic of ChinaView further author information
,
Yao Denga NHC Key Laboratory of Biosafety, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, People’s Republic of ChinaView further author information
,
Jing Chenc Center for Drug Safety Evaluation and Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, People’s Republic of ChinaView further author information
,
Likun Gongc Center for Drug Safety Evaluation and Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, People’s Republic of ChinaView further author information
,
Weiliang Zhub State Key Laboratory of Drug Research; Drug Discovery and Design Center, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, People’s Republic of ChinaView further author information
,
Zhijian Xub State Key Laboratory of Drug Research; Drug Discovery and Design Center, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, People’s Republic of ChinaCorrespondence[email protected]
View further author information
&
Wenjie Tana NHC Key Laboratory of Biosafety, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, People’s Republic of ChinaCorrespondence[email protected]
View further author information
 show all
Article: 2373309 | Received 27 Dec 2023, Accepted 22 Jun 2024, Published online: 15 Jul 2024

References

  • Shchelkunova GA, Shchelkunov SN. Smallpox, monkeypox and other human orthopoxvirus infections. Viruses. 2023;15(1):103. doi:10.3390/v15010103
  • Shchelkunov SN. Emergence and reemergence of smallpox: the need for development of a new generation smallpox vaccine. Vaccine. 2011;29:D49–D53. doi:https://doi.org/10.1016/j.vaccine.2011.05.037.
  • Lum FM, Torres-Ruesta A, Tay MZ, et al. Monkeypox: disease epidemiology, host immunity and clinical interventions. Nat Rev Immunol. 2022;22(10):597–613. doi:10.1038/s41577-022-00775-4
  • https://worldhealthorg.shinyapps.io/mpx global/.
  • Saied AA, Dhawan M, Metwally AA, et al. Disease history, pathogenesis, diagnostics, and therapeutics for human monkeypox disease: A comprehensive review. Vaccines (Basel). 2022;10(12):2091. doi:10.3390/vaccines10122091
  • Hoy SM. Tecovirimat: first global approval. Drugs. 2018;78(13):1377–1382. doi:10.1007/s40265-018-0967-6
  • Delaune D, Iseni F. Drug development against smallpox: present and future. Antimicrob Agents Chemother. 2020;64(4):10–1128. doi:10.1128/AAC.01683-19
  • Lederman ER, Davidson W, Groff HL, et al. Progressive vaccinia: case description and laboratory-guided therapy with vaccinia immune globulin, ST-246, and CMX001. J Infect Dis. 2012;206(9):1372–1385. doi:10.1093/infdis/jis510
  • Hung YP, Lee CC, Lee JC, et al. A brief on new waves of monkeypox and vaccines and antiviral drugs for monkeypox. J Microbiol Immunol Infect. 2022;55(5):795–802. doi:10.1016/j.jmii.2022.08.016
  • Adler H, Gould S, Hine P, et al. Clinical features and management of human monkeypox: a retrospective observational study in the UK. Lancet Infect Dis. 2022;22(8):1153–1162. doi:10.1016/S1473-3099(22)00228-6
  • Vaughan A, Aarons E, Astbury J, et al. Two cases of monkeypox imported to the United Kingdom, September 2018. Euro Surveill Bull Eur sur les Mal Transm = Eur Commun Dis Bull. 2018;23(38):1800509. doi:10.2807/1560-7917.ES.2018.23.38.1800509
  • Rizk JG, Lippi G, Henry BM, et al. Prevention and treatment of monkeypox. Drugs. 2022;82(9):957–963. doi:10.1007/s40265-022-01742-y
  • Höer A, Schöneberg T, Harteneck C, et al. Enhancement of phospholipase D activity following baculovirus and adenovirus infection in Sf9 and COS-7 cells. Biochim Biophys Acta. 1998;1393(2-3):325–335. doi:10.1016/S0005-2760(98)00087-3
  • Li H, Zhang H, Ding K, et al. The evolving epidemiology of monkeypox virus. Cytokine Growth Factor Rev. 2022;68:1–12. doi:10.1016/j.cytogfr.2022.10.002

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.